Big Pharma is profiting from fake THC/CBD drugs. Some cannabis legalization advocates say the marketing of those drugs is part of what's driving the crackdown on pot.
"The biggest problem with this scandal isn't that Cambridge Analytica is shady -- it's that Facebook is," argues one journalist.
Simon Johnson, former chief economist of the International Monetary Fund, is a professor at the MIT Sloan School of Management, a senior fellow at the Peterson Institute for International Economics, and a member of the CBO’s Panel of Economic Advisers. He is a co-founder of The Baseline Scenario.